NOVADIGM THERAPEUTICS, INC.;LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER
发明人:
YEAMAN, MICHAEL R.,EDWARDS, JOHN E., JR.,FILLER, SCOTT G.,IBRAHIM, ASHRAF S.,FU, YUE,HENNESSEY, JOHN P., JR.
申请号：
CA2842626
公开号：
CA2842626A1
申请日:
2012.07.20
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The invention features a method of vaccinating a mammal against Staphylococcus aureus which includes the steps of: a) identifying a mammal at risk for the development of a Staphylococcus aureus skin or soft tissue infection； and b) administering to said mammal an immunogenic amount of a vaccine that includes a polypeptide including an isolated agglutinin-like sequence (Als) 3 protein (Als3p), or an immunogenic fragment thereof, in a pharmaceutically acceptable medium.
